{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T18:08:54Z","timestamp":1772302134163,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijcrp.2025.200558","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:14:39Z","timestamp":1764836079000},"page":"200558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9"],"prefix":"10.1016","volume":"28","author":[{"given":"Pradeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudesh","family":"Prajapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-7580","authenticated-orcid":false,"given":"Akshyaya","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravesh","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhanshu","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2025.200558_bib1","unstructured":"World Health Organisation, Non communicable diseases, (n.d.). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases (accessed July 3, 2025)."},{"key":"10.1016\/j.ijcrp.2025.200558_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3390\/ijerph18041773","article-title":"Metabolic syndrome and coronary artery disease risk: a meta-analysis of observational studies","volume":"18","author":"Alshammary","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ijcrp.2025.200558_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12055-023-01652-y","article-title":"Does high dose statin pretreatment affect global strains in patients undergoing valve replacement","volume":"40","author":"Prajapathi","year":"2024","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcrp.2025.200558_bib4","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"European atherosclerosis society consensus panel, Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200558_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"AKCEA-APO(a)-LRx study investigators, lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib6","series-title":"ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk","author":"Baigent","year":"2019"},{"key":"10.1016\/j.ijcrp.2025.200558_bib7","first-page":"8","article-title":"Lipid association of India expert consensus statement on management of dyslipidemia in Indians 2020: part III","volume":"68","author":"Puri","year":"2020","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.ijcrp.2025.200558_bib8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Open-label study of long-term evaluation against LDL cholesterol (OSLER) investigators, efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators, evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"ODYSSEY OUTCOMES committees and investigators, alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib11","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"ORION-10 and ORION-11 investigators, two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib12","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200558_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4093\/dmj.2017.0081","article-title":"Serum levels of PCSK9 are associated with coronary angiographic severity in patients with acute coronary syndrome","volume":"42","author":"Bae","year":"2018","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ijcrp.2025.200558_bib14","unstructured":"G. Sianos, M.-A. Morel, A. Kappetein, M.-C. Morice, A. Colombo, K.D. Dawkins, M. van den Brand, N. van Dyck, M.E. Russell, P.W. Serruys, The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease, (n.d.). https:\/\/eurointervention.pcronline.com\/article\/the-syntax-score-an-angiographic-tool-grading-the-complexity-of-coronary-artery-disease (accessed July 6, 2025)."},{"key":"10.1016\/j.ijcrp.2025.200558_bib15","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200558_bib16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators, evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"ODYSSEY OUTCOMES committees and investigators, effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200558_bib18","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.18410\/jebmh\/2019\/572","article-title":"Lp(a), ApoB and ApoB\/ApoA1 ratio as potential serum markers for predicting early-onset acute coronary syndrome","volume":"6","author":"James","year":"2019","journal-title":"Jebmh"},{"key":"10.1016\/j.ijcrp.2025.200558_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1515\/CCLM.2006.163","article-title":"The ratio of apoB\/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease","volume":"44","author":"Rasouli","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijcrp.2025.200558_bib20","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182096","article-title":"Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels","volume":"39","author":"Cai","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ijcrp.2025.200558_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003012","article-title":"Lipoprotein(a) interactions with low-density lipoprotein cholesterol and other cardiovascular risk factors in premature acute coronary syndrome (ACS)","volume":"5","author":"Afshar","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2025.200558_bib22","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcrp.2025.200558_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106294","article-title":"Plasma PCSK9 levels are elevated with acute myocardial infarction in two independent retrospective angiographic studies","volume":"9","author":"Almontashiri","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcrp.2025.200558_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.diabet.2017.07.009","article-title":"Circulating PCSK9 levels in acute coronary syndrome: results from the PC-SCA-9 prospective study","volume":"43","author":"Cariou","year":"2017","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijcrp.2025.200558_bib25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.cell.2021.01.005","article-title":"Genome engineering for crop improvement and future agriculture","volume":"184","author":"Gao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ijcrp.2025.200558_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4093\/dmj.2017.0081","article-title":"Serum levels of PCSK9 are associated with coronary angiographic severity in patients with acute coronary syndrome","volume":"42","author":"Bae","year":"2018","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ijcrp.2025.200558_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.hlc.2023.08.006","article-title":"Meta-analysis of the current research on the relationship between blood lipid levels and the occurrence of atrial fibrillation","volume":"32","author":"Hay\u0131ro\u011flu","year":"2023","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcrp.2025.200558_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.12997\/jla.2022.11.3.280","article-title":"The triglyceride-glucose index can predict long-term major adverse cardiovascular events in Turkish patients with high cardiovascular risk","volume":"11","author":"Hay\u0131ro\u011flu","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.ijcrp.2025.200558_bib29","first-page":"576","article-title":"Evaluation of websites reached using google in the modern digital era related to approach to cholesterol","volume":"48","author":"Hay\u0131ro\u011flu","year":"2020","journal-title":"Turk Kardiyol. Dernegi Arsivi"},{"key":"10.1016\/j.ijcrp.2025.200558_bib30","first-page":"300","article-title":"Intensive lipid-lowering therapy following acute coronary syndrome: the earlier the better","volume":"12","author":"Pradhan","year":"2025","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.ijcrp.2025.200558_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0021-9150(98)00242-1","article-title":"Upregulation of cholesterol synthesis after acute myocardial infarction--is cholesterol a positive acute phase reactant?","volume":"142","author":"Pfohl","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcrp.2025.200558_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0735-1097(93)90213-K","article-title":"Myocardial injury: the acute phase response and lipoprotein metabolism","volume":"22","author":"Rosenson","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200558_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102727","article-title":"Prevention of cardiovascular disease for healthy aging and longevity: a new scoring system and related \u201cmechanisms-hallmarks-biomarkers,\u201d","volume":"107","author":"Hu","year":"2025","journal-title":"Ageing Res. Rev."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:39:54Z","timestamp":1772300394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S2772487525001965"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200558","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200558"}}